eMed has raised $200 million in a Series A funding round led by AON Consulting, Inc. The financing will enhance eMed's AI platform and support employer healthcare solutions.
PRIVATEMar 26, 2026
Amount Raised
$200 Million
Round Type
Series A
MiamiHealth Care
Investors
Tom BradyJeff AroninAra CohenAntonio GraciasJoe LonsdaleR.J. MelmanTom RickettsLinda YaccarinoAON Consulting, Inc.
Description
Miami based eMed today announced it has raised $200 million in funding at a $2 billion plus valuation. The round included investors such as Tom Brady and Jeff Aronin, among others. This funding will advance eMed's agentic AI platform and support a new healthcare model for employers. eMed aims to change the landscape of GLP-1 medications as a workplace benefit.
Who to call at eMed, and when
A new round usually means eMed is about to hire and buy. The teams that reach out first get the meeting.
An alert the day eMed raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at eMed, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
eMed
Location
Miami, Florida, United States
About
eMed® is the world's first end-to-end GLP-1 care platform built on Empathetic AI™. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment eMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MiamiHealth Care